Regeneron COVID-19 treatment enters final stage trials

The drug is a combination of two antibodies that block the coronavirus’ “spike protein” which it uses to invade human cells.
WASHINGTON – The pharmaceutical firm Regeneron on Monday announced it wa…
Read More